Adaptive Biotechnologies (ADPT) Stock Price

$7.33 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    3

  • Fundamental

    2

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Adaptive Biotechnologies, AI stock picks, stock alerts and much more.

Sign up

ADPT AI Stock Analysis

AI stock analysis for ADPT is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Adaptive Biotechnologies (ADPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Adaptive Biotechnologies (ADPT) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Adaptive Biotechnologies (ADPT), currently trading at $7.33, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About ADPT

LSE

  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

  • Symbol

    ADPT

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.1B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $22.52
1.5%
5
INO Inovio Pharmaceuticals
INO		 $1.74
1.2%
1
MRNA Moderna
MRNA		 $24.72
1.9%
3
AVXL Anavex Life Sciences
AVXL		 $8.95
1.2%
5
BBIO BridgeBio Pharma
BBIO		 $33.87
0.1%
4

News

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
April 10, 2025. globenewswire.com
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
April 8, 2025. globenewswire.com
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
March 11, 2025. globenewswire.com
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
February 12, 2025. zacks.com

ADPT Alternative Data

Web Traffic

Adaptive Biotechnologies receives an estimated 28922 monthly visitors to adaptivebiotech.com.

  • Web Traffic

    28922

  • Change from Previous Month

    12.2%

  • 3 Month Change

    13%

  • YoY Change

    13%

News Mentions

Adaptive Biotechnologies was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Adaptive Biotechnologies has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

Twitter Followers

Adaptive Biotechnologies has 4,579 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    4579

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.6%

  • YoY Change

    1.6%

Facebook Engagement

Adaptive Biotechnologies has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    0%

  • 1 Month Change

    83.3%

  • 3 Month Change

    0%

  • YoY Change

    0%

Instagram Followers

Adaptive Biotechnologies has 1,217 Instagram Followers on its main Instagram account, up by 0.2% over the last month.

  • Instagram Followers

    1217

  • Daily Change

    0.1%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.8%

  • YoY Change

    0.8%

LinkedIn Followers

30,501 are following Adaptive Biotechnologies on LinkedIn, up by 0.9% over the last month.

  • LinkedIn Followers

    30501

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    2.5%

Job Postings

Adaptive Biotechnologies has an estimated 13 open job postings, which is down -13.3% over the last month.

  • Job Postings

    13

  • Daily Change

    0%

  • 1 Month Change

    13.3%

  • 3 Month Change

    18.8%

  • YoY Change

    18.8%

LinkedIn Employees

According to LinkedIn, Adaptive Biotechnologies has 653 employees.

  • LinkedIn Employees

    653

  • Daily Change

    0.2%

  • 1 Month Change

    0%

  • 3 Month Change

    2.5%

  • YoY Change

    2.5%

Business Outlook

According to employee reviews, the business outlook among employees at Adaptive Biotechnologies is 28 out of 100 (bearish).

  • Business Outlook

    28

  • Change from Previous Month

    40%

  • 3 Month Change

    0%

  • YoY Change

    0%

ADPT Financials

ADPT Key Metrics

  • Total Revenue

    $47.5M

  • Net Income

    -$33.7M

  • Earnings per Share

    -$0.23

  • Free cash flow

    -$12.6M

  • EBITDA

    -$26.3M

  • EBITDA Ratio

    -0.554521

  • Total Assets

    $539.4M

ADPT 2-year Revenue & Income
ADPT 2-year Free Cash Flow

ADPT Technicals

ADPT SMA
ADPT RSI

FAQ

What's the current price of Adaptive Biotechnologies (ADPT) Stock?
The price of an Adaptive Biotechnologies (ADPT) share is $7.33.

What's the market cap of Adaptive Biotechnologies?
The current market cap of Adaptive Biotechnologies is 1.1B.

Should I buy or sell ADPT?
Adaptive Biotechnologies exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Adaptive Biotechnologies a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Adaptive Biotechnologies stock. There are several bearish signals and market challenges that could negatively impact Adaptive Biotechnologies' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Adaptive Biotechnologies (ADPT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Adaptive Biotechnologies stock right now, as the outlook appears bearish.

What are some stocks similar to Adaptive Biotechnologies (ADPT) that investors often compare it to?
Adaptive Biotechnologies (ADPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Adaptive Biotechnologies' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Adaptive Biotechnologies' stock price to be around $6.77 in 2026. Starting from the current price of $7.33, this represents a 7.7% change in price, indicating a bearish outlook for the stock.

How to buy Adaptive Biotechnologies (ADPT) Stock?
Adaptive Biotechnologies stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Adaptive Biotechnologies shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.